Clik here to view.
SABCS 2014: Immunotherapy Shows Early Promise for Triple-negative Breast...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope for women with a very challenging form of breast cancer—triple-negative breast...
View ArticleClik here to view.
SABCS 2014: Trial Testing Pictilisib-Fulvestrant Combo Generates Mixed Results
Data from the phase II FERGI trial presented Dec. 10 at the San Antonio Breast Cancer Symposium showed no improvement overall from using a pictilisib-fulvestrant combination to treat women with...
View ArticleClik here to view.
SABCS 2014: A Bullet Against Breast Cancer Women Aren’t Using
Guest Post by Anees B. Chagpar Yale Cancer Center Amid all the headlines coming out of the San Antonio Breast Cancer Symposium last week—and there were plenty—there was one story that I hope to see...
View ArticleCancer Research Catalyst’s 10 Most-read Blog Posts of 2014
New Year’s Day marked the six month anniversary of the AACR’s blog, which seemed an appropriate time to examine what people are really reading on this new communications vehicle. Since our launch July...
View ArticleClik here to view.
Ongoing Progress Against Cancer: New Breast Cancer Therapeutic Approved
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week when palbociclib (Ibrance) was approved for use in combination with the...
View ArticleClik here to view.
Stepping Into the Era of Combination Cancer Therapies, Part 2: Combining...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015 that hold promise for combination cancer therapies, I discussed clinical trials that tested...
View ArticleHow Should DCIS Be Treated?
Ductal carcinoma in situ (DCIS)—stage 0 breast cancer that starts in a duct and has not spread into surrounding tissue—is the fourth most common cancer diagnosis among women in the United States. DCIS...
View ArticleClik here to view.
A Family Affair: Breast Cancer Prevention for Mothers, Daughters, and Women...
Guest Post by Graham A. Colditz, MD, DrPH Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine In today’s information-heavy world, it’s hard for any...
View ArticleClik here to view.
Helping Patients Share Their Stories
Jamie Holloway. Dealing with a cancer diagnosis is overwhelming. You worry not only about yourself, but also about the family and friends who love you. How are you going to manage treatments? How are...
View ArticleClik here to view.
Developing a Career in Breast Cancer Research Through the AACR Grants Program
Eddy Shih-Hsin Yang, MD, PhD, associate professor and Regional Oncology Active Research (ROAR) Southeast Cancer Foundation Endowed Chair at the University of Alabama-Birmingham (UAB), is an expert in...
View ArticleClik here to view.
AACR Past-president Carlos Arteaga to Receive Prestigious Medical Award
Carlos L. Arteaga, MD, past-president of the American Association for Cancer Research (AACR), has been selected to receive the 2015 Prize for Scientific Excellence in Medicine from the American-Italian...
View ArticleClik here to view.
A History of the San Antonio Breast Cancer Symposium
Editor’s Note: The mission of the 2015 San Antonio Breast Cancer Symposium is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research,...
View ArticleClik here to view.
SABCS 2015: Symposium Co-director Carlos L. Arteaga Previews Important...
It’s that time of year again. The 38th annual San Antonio Breast Cancer Symposium (SABCS) is happening Dec. 8-12. The symposium is a joint effort of the Cancer Therapy & Research Center at UT...
View ArticleClik here to view.
SABCS 2015: Denosumab Improves Outcomes for Patients Taking Aromatase Inhibitors
Data from the phase III ABCSG-18 clinical trial, presented Dec. 9 at the San Antonio Breast Cancer Symposium, showed that denosumab, which was previously reported to reduce clinical fractures, was also...
View ArticleClik here to view.
SABCS 2015: Less Treatment Is More for Early-stage Breast Cancer
Two studies show that breast-conserving surgery plus radiation may be a better option than mastectomy plus reconstruction for women with early-stage breast cancer because it reduces complications,...
View ArticleClik here to view.
SABCS 2015: Good News for Patients With HER2-positive Breast Cancer
Data from the phase III TH3RESA clinical trial presented Dec. 11 at the San Antonio Breast Cancer Symposium showed that trastuzumab emtansine (T-DM1 [Kadcyla]) improved median overall survival for...
View ArticleClik here to view.
SABCS 2015: Choosing Between Anastrozole and Tamoxifen After Stage 0 Diagnosis
Data from two clinical trials presented at the San Antonio Breast Cancer Symposium showed that for women with estrogen receptor-positive ductal carcinoma in situ (DCIS), the choice between anastrozole...
View ArticleClik here to view.
SABCS 2015: Attendees From 95 Countries Leave With Latest Breast Cancer...
With the 38th annual San Antonio Breast Cancer Symposium wrapped up, here are some important findings featured at the meeting, but not covered in this space in the last few days: Data from the phase...
View ArticleClik here to view.
Patients Power AACR Advocacy Efforts
AACR Scientist↔Survivor Program Participant Kim Hall Jackson. Photo by Colin M. Lenton. Kim Hall Jackson is coming into her season. Hall Jackson beat colorectal cancer in 2009, and has gone on to...
View Article10 Most Popular Cancer Research Catalyst Blog Posts of 2015
It’s that time of year when we reflect on the progress we made over the past 12 months – and in the world of cancer research, that progress has been monumental. From approval of the first cancer...
View Article
